World's Best Scientists 2026 revealed!
Yoram Bouhnik

Yoram Bouhnik

D-Index & Metrics

Medicine

D-Index
93
Citations
29837
World Ranking
10942
National Ranking
339

Overview

Yoram Bouhnik is affiliated with Beaujon Hospital in France and has contributed extensively to medical research, particularly in gastroenterology and related fields. Their work spans a significant number of publications and focuses on several contemporary issues in inflammatory bowel disease treatment and management.

The main fields of study for Yoram Bouhnik include Medicine and Biochemistry, Genetics and Molecular Biology. Their research delves into subfields such as Genetics, Epidemiology, Immunology, Surgery, and Rheumatology.

Their primary research topics encompass:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Biosimilars and Bioanalytical Methods
  • Autoimmune and Inflammatory Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Diagnosis and treatment of tuberculosis
  • Pharmaceutical studies and practices

Yoram Bouhnik has published recent papers focusing on treatment effectiveness and safety in chronic gastrointestinal conditions. Notable publications include:

  • The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor (2020) in Alimentary Pharmacology & Therapeutics
  • Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial (2023) in The Lancet. Gastroenterology & Hepatology
  • Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study (2021) in The Lancet. Gastroenterology & Hepatology
  • Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID (2020) in The American Journal of Gastroenterology
  • Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study (2020) in Alimentary Pharmacology & Therapeutics

The researcher frequently collaborates with several co-authors, including:

  • Laurent Peyrin-Biroulet
  • David Laharie
  • Aurélien Amiot
  • Lucine Vuitton
  • Stéphane Nancey

Publications by Bouhnik have appeared in a range of academic journals, with multiple entries in:

  • Journal of Crohn's and Colitis
  • Gastroenterology
  • Digestive and Liver Disease
  • Alimentary Pharmacology & Therapeutics
  • Inflammatory Bowel Diseases

Best Publications

  • Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

    Laurent Beaugerie;Nicole Brousse;Anne Marie Bouvier;Jean Frédéric Colombel

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

    Gert Van Assche;Axel Dignass;Walter Reinisch;C. Janneke van der Woude

  • Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

    J. Panes;Y. Bouhnik;W. Reinisch;J. Stoker

  • Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

    Edouard Louis;Jean–Yves Mary;Gwenola Vernier–Massouille;Jean–Charles Grimaud

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

    David Laharie;Arnaud Bourreille;Julien Branche;Matthieu Allez

  • The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study

    Yoram Bouhnik;Laurent Raskine;Guy Simoneau;Eric Vicaut

  • Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

    Hongxiang Liu;Agnes Ruskon-Fourmestraux;Anne Lavergne-Slove;Hongtao Ye

  • Short-Chain Fructo-Oligosaccharide Administration Dose-Dependently Increases Fecal Bifidobacteria in Healthy Humans

    Yoram Bouhnik;Kouroche Vahedi;Lotfi Achour;Alain Attar

  • A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.

    Marc Lémann;Jean-Yves Mary;Jean-Frédéric Colombel;Bernard Duclos

  • Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II

    Georgia Malamut;Pauline Afchain;Virginie Verkarre;Thierry Lecomte

  • Administration of Transgalacto-Oligosaccharides Increases Fecal Bifidobacteria and Modifies Colonic Fermentation Metabolism in Healthy Humans

    Yoram Bouhnik;Bernard Flourié;Laurence D'Agay-Abensour;Philippe Pochart

  • Abnormal Intestinal Intraepithelial Lymphocytes in Refractory Sprue

    Christophe Cellier;Natacha Patey;Laurent Mauvieux;Bana Jabri

  • Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease

    Tamara Matysiak-Budnik;Ivan Cruz Moura;Ivan Cruz Moura;Michelle Arcos-Fajardo;Michelle Arcos-Fajardo;Corinne Lebreton;Corinne Lebreton

  • Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease

    Pierre Desreumaux;Arnaud Foussat;Matthieu Allez;Laurent Beaugerie

  • Risk Factors for Intra-Abdominal Septic Complications After a First Ileocecal Resection for Crohn’s Disease: A Multivariate Analysis in 161 Consecutive Patients

    Arnaud Alves;Yves Panis;Yoram Bouhnik;Marc Pocard

  • Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED–ECCO consensus

    A. Bourreille;A. Ignjatovic;L. Aabakken;E. V. Loftus

  • Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease

    Magali Fasseu;Xavier Tréton;Xavier Tréton;Cécile Guichard;Cécile Guichard;Eric Pedruzzi;Eric Pedruzzi

  • Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

    Geert D'Haens;Severine Vermeire;Guy Lambrecht;Filip Baert

  • Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.

    Kouroche Vahedi;Françoise Mascart;Jean Yves Mary;Jean Eric Laberenne

  • Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial.

    Alain Attar;Bernard Flourié;Jean–Claude Rambaud;Claire Franchisseur

Frequent Co-Authors

Matthieu Allez
Matthieu Allez Université Paris Cité
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Yves Panis
Yves Panis Université Paris Cité
Laurent Peyrin-Biroulet
Laurent Peyrin-Biroulet University of Lorraine
Marc Lémann
Marc Lémann Université Paris Cité
Xavier Hébuterne
Xavier Hébuterne Université Côte d'Azur
Edouard Louis
Edouard Louis University of Liège
Franck Carbonnel
Franck Carbonnel University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring options beyond traditional Medicine degrees can open doors to rewarding careers in healthcare. Many students look for flexible, accessible programs that allow them to gain vital skills online. For example, if you’re interested in administrative roles, consider medical billing and coding schools that accept fafsa. This path can help you enter the healthcare field quickly with support from federal aid.

Nursing also offers multiple online pathways. You might wonder, do you have to take a teas test for lpn? Many reputable LPN programs waive entrance exams, making it easier to start your nursing education. For those aiming at management, an healthcare administration accelerated degree can fast-track you to leadership positions.

Already a registered nurse? Advancing to a nurse practitioner role is streamlined with rn to fnp bridge programs. These online bridge degrees help RNs become Family Nurse Practitioners efficiently while balancing work and study.

Best Scientists Citing Yoram Bouhnik

Trending Scientists

Recently Published Articles